Treatment of COVID-19 Pneumonia and Acute Respiratory Distress With Ramatroban, a Thromboxane A(2) and Prostaglandin D(2) Receptor Antagonist: A Four-Patient Case Series Report

Hypoxemia in COVID-19 pneumonia is associated with hospitalization, mechanical ventilation, and mortality. COVID-19 patients exhibit marked increases in fatty acid levels and inflammatory lipid mediators, predominantly arachidonic acid metabolites, notably thromboxane B(2) >> prostaglandin E(2...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogletree, Martin L., Chander Chiang, Kate, Kulshrestha, Rashmi, Agarwal, Aditya, Agarwal, Ashutosh, Gupta, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355466/
https://www.ncbi.nlm.nih.gov/pubmed/35935851
http://dx.doi.org/10.3389/fphar.2022.904020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355466/
https://www.ncbi.nlm.nih.gov/pubmed/35935851
http://dx.doi.org/10.3389/fphar.2022.904020

Ejemplares similares